NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

2 hedge funds and large institutions have $13 invested in Navidea Biopharmaceuticals Inc. in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
BBA
1
Baader Bank Aktiengesellschaft
Germany
$0
2
ASN
2
Advisory Services Network
Georgia
$0
3
BCMLT
3
Beacon Capital Management LLC (Tennessee)
Tennessee
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PA
1
Parallel Advisors
California
$13 350 – –
BBA
2
Baader Bank Aktiengesellschaft
Germany
– – -10,630 Closed
ASN
3
Advisory Services Network
Georgia
– – -250 Closed
BCMLT
4
Beacon Capital Management LLC (Tennessee)
Tennessee
– – -10 Closed
WWP
5
WR Wealth Planners
Missouri
$0 10 +10 New